<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01079585</url>
  </required_header>
  <id_info>
    <org_study_id>TASMC-10-NV-014-CTIL</org_study_id>
    <nct_id>NCT01079585</nct_id>
  </id_info>
  <brief_title>The Effect of 40gr Okara on Gastric Emptying</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tel-Aviv Sourasky Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Nutrigal LTD</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Tel-Aviv Sourasky Medical Center</source>
  <brief_summary>
    <textblock>
      The effect of 40gr Okara, on gastric emptying of standard meal (Muffin cake)
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This trail will be a single blinded, cross-over design. The study population will include 10
      subjects. The patients will be randomly assigned to receive one of two Muffin cakes, with or
      without 40 grams Okara on three occasions (three visits). In two visits the subject will
      receive a Muffin cake with 40 grams Okara (but with similar caloric value), and in one visit
      a Muffin cake without Okara.

      Postprandial gastric emptying time will be measured for each subject, by 13C Breath Test.

      Okara is a natural water extracted food grade soy product, contains approximately 35% protein
      (mfb), and about 43% of dietary fibers.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>March 2010</start_date>
  <completion_date type="Anticipated">December 2010</completion_date>
  <primary_completion_date type="Anticipated">October 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <masking>Single</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To investigate the influence of 40 gram Okara on gastric emptying</measure>
  </primary_outcome>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Healthy People</condition>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Nutrigal Okara - 100</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy volunteers

          -  Age 20-65 years old

          -  Written Informed Consent

        Exclusion Criteria:

          -  History of gastro-intestinal surgery

          -  On medication that may influence gastric emptying, or medication for weight loss

          -  Patient on PPI treatment, H2 Blockers or medication for weight loss

          -  Known allergies to soy

          -  Pregnancy or breast-feeding

          -  Smoking

          -  Athletes

          -  Metabolic syndrome or diabetes mellitus

          -  Family history of metabolic syndrome or diabetes mellitus

          -  Weight loss &gt; 2 kg during two months before the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Nachum Vaisman, Prof'</last_name>
    <phone>009-972-3-6974807</phone>
    <email>vaisman@tasmc.health.gov.il</email>
  </overall_contact>
  <location>
    <facility>
      <name>Tel Aviv Medical Center</name>
      <address>
        <city>Tel Aviv</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Nachum Vaisman</last_name>
      <phone>00-972-3-6974807</phone>
      <email>vaisman@tasmc.health.gov.il</email>
    </contact>
    <investigator>
      <last_name>Nachum Vaisman, Prof'</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>February 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 17, 2010</study_first_submitted>
  <study_first_submitted_qc>March 2, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 3, 2010</study_first_posted>
  <last_update_submitted>March 2, 2010</last_update_submitted>
  <last_update_submitted_qc>March 2, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 3, 2010</last_update_posted>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

